OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Herbst on the Benefit of Adjuvant Osimertinib in EGFR-Mutant NSCLC

June 2nd 2020

Roy S. Herbst, MD, PhD, discusses the benefit of adjuvant osimertinib demonstrated in patients with stage II to IIIA EGFR-mutant non–small cell lung cancer in the phase 3 ADAURA trial.

Dr. Plimack on Updated Findings of the KEYNOTE-426 Study in RCC

June 2nd 2020

Elizabeth R. Plimack, MD, MS, discusses the updated findings from the phase 3 KEYNOTE-426 study in patients with previously untreated, advanced renal cell carcinoma.

Dr. Cutler on Remaining Challenges in GVHD

June 2nd 2020

Corey S. Cutler, MD, MPH, FRCPC, discusses remaining challenges in graft-versus-host disease.

Dr. Katz on Determining Low-Risk Disease in Prostate Cancer

June 2nd 2020

Aaron E. Katz, MD, FACS, discusses strategies for determining low-risk prostate cancer.

Dr. Santos on the FDA Approval of Ramucirumab/Erlotinib in EGFR-Mutant NSCLC

May 30th 2020

Edgardo S. Santos, MD, FACP, FCCP, discusses the FDA approval of the combination of ramucirumab and erlotinib for the frontline treatment of patients with metastatic non–small cell lung cancer (NSCLC) whose tumors harbor EGFR Ex19del or Ex21 substitution mutations.

Dr. Weitzman on Reusing Treatments in Relapsed/Refractory Multiple Myeloma

May 30th 2020

James Weitzman, MD, discusses reusing treatments in patients with relapsed/refractory multiple myeloma.

Dr. Pishvaian on FDA Approval of Atezolizumab Plus Bevacizumab in HCC

May 29th 2020

Michael J. Pishvaian, MD, PhD, discusses the FDA approval of the combination of atezolizumab (Tecentriq) and bevacizumab (Avastin) for the treatment of patients with hepatocellular carcinoma (HCC).

Dr. O'Donnell on Transplant Considerations in Multiple Myeloma

May 29th 2020

Betsy O'Donnell, MD, discusses transplant considerations in patients with multiple myeloma.

Dr. Branagan on the Role of Transplant in High-Risk Multiple Myeloma

May 28th 2020

Andrew Branagan, MD, discusses the role of autologous stem cell transplantation in patients with high-risk multiple myeloma.

Dr. Mizrahi on Targeting Treatment in Metastatic Colorectal Cancer

May 28th 2020

Jonathan Mizrahi, MD, discusses efforts being made to target treatment for patients with metastatic colorectal cancer.

Dr. Bazhenova on Ongoing Clinical Trials With Immunotherapy in NSCLC

May 28th 2020

Lyudmila A. Bazhenova, MD, discusses ongoing clinical trials in non–small cell lung cancer that are investigating the utility of immunotherapy.

Dr. Brody on Addressing Acquired Resistance to Immunotherapy in Non-Hodgkin Lymphoma

May 28th 2020

Joshua Brody, MD, discusses addressing required resistance to immunotherapy in non-Hodgkin lymphoma.

Dr. Otterson on the Utility of Immunotherapy in NSCLC

May 28th 2020

Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Dr. Bertino on the Impact of the EGFR-Mutated Subset Analysis of IMpower150 in NSCLC

May 27th 2020

Erin M. Bertino, MD, discusses the impact of the EGFR-mutated subset analysis of the phase 3 IMpower150 trial on the use of immunotherapy in patients with non–small cell lung cancer.

Dr. Brammer on Data With Inotuzumab Ozogamicin in ALL

May 27th 2020

Jonathan E. Brammer, MD, discusses data that have been reported with inotuzumab ozogamicin (Besponsa) in acute lymphoblastic leukemia (ALL).

Dr. Mims on the Beat AML Master Trial in AML

May 27th 2020

Alice S. Mims, MD, discusses the Beat AML Master Trial in acute myeloid leukemia (AML).

Dr. Kaplan on Research With Bispecific Monoclonal Antibodies in Follicular Lymphoma

May 27th 2020

Lawrence D. Kaplan, MD, discusses research with bispecific monoclonal antibodies in follicular lymphoma.

Dr. Rosenberg on the KEYNOTE-045 Trial in Advanced Urothelial Cancer

May 27th 2020

Jonathan E. Rosenberg, MD, discusses the phase 3 KEYNOTE-045 trial in advanced urothelial cancer.

Dr. Smaglo on the Role of Immunotherapy in Advanced Gastric Cancer

May 27th 2020

Brandon G. Smaglo, MD, FACP, discusses the role of immunotherapy in advanced gastric cancer.

Dr. Le on Research Needed to Address Unmet Needs in mCRC

May 27th 2020

Phat Le, MD, discusses research efforts that are needed to address unmet needs in metastatic colorectal cancer.